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Summary 
The arterial wall is exposed to mechanical forces associated with the flowing blood.  In vivo the 
artery is subject to an axial load, a wall stress in the circumferential direction due to the internal 
pulsatile pressure and a frictional stress, the wall shear stress, generated by the moving blood.  
The cells are sensitive to changes in the magnitude and frequency of these stresses which are 
important modulators of cell function.  
Deviation of the mechanical environment of the cells from homeostatic levels stimulates vessel 
wall remodeling, increasing the production of structural proteins and degradative enzymes until a 
new homeostatic state is achieved.  The haemodynamic environment can give rise to deleterious 
remodeling,  for example, atherosclerosis or aneurysms. 
Clinical research has historically focused on the two main strategies of in vivo and in vitro 
experimentation. The concept of applying scientific theory to direct clinical applications is 
relatively recent. In this paper we focus on the interaction of wall shear stress with the 
endothelium and discuss how ‘state of the art’ computer modeling techniques can provide 
valuable data to aid understanding.  Such data may be used to inform experiment and further, 
may help identify the key features of this complex system. 
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Introduction 
The structure of the arterial wall (Figure 1a) is maintained by cells (endothelial cells, smooth 
muscle cells and fibroblasts) that degrade and deposit the structural proteins of which it is 
comprised.  The functionality of these cells is regulated by mechanical signals associated with the 
pulsatile flow of blood through the lumen. 
Figure 1 and Figure 2 here.  
 
There are two types of stress on the vessel wall, one associated with mechanical equilibrium 
under the internal pressure and one associated with the viscous resistance of flowing blood 
(Figure 2).  In vivo, the artery is a pre-stretched material under an internal pressure load (1). 
Internal pressure produces a stress in the circumferential direction.  Neglecting viscoelastic and 
inertial effects in the vessel wall, circumferential stress is proportional to the instantaneous 
applied pressure. Interestingly, in addition to the cyclic circumferential stress an axial load is 
present.  For unfixed human cerebral vessels the average in vivo axial stretch of is 1.31 (2). This 
mechanical environment results in typical circumferential stresses of 150KPa and typical axial 
stresses of 75 to 125KPa (3). 
The flow is driven by a pressure gradient along the axis of the vessel.  It is often assumed that the 
velocity of the blood at the wall of the vessel is zero (the no-slip boundary condition), and the 
frictional stress generated at the wall by the moving blood sliding over this stationary layer is 
called the wall shear stress (WSS).  The cells are sensitive to changes in the magnitude and 
frequency of these stresses and both are important modulators of cell function. The internal 
pressure, and thus the circumferential stress, typically varies rapidly in time but only slowly in 
space. The cyclic stress, or the change in stress over the cardiac cycle, might be as important as 
the absolute magnitude of stress. As the pressure gradient changes over the cardiac cycle, so too 
the WSS changes. The oscillatory shear index (OSI) is a measure of the change of direction of 
the flow over the cardiac cycle. In the smaller vessels the flow is essentially unidirectional thus 
the OSI is zero. In larger arteries there is often some reverse flow at some point in the cardiac 
cycle, giving rise to oscillatory shear stresses.  Significant oscillatory shear is, however, usually 
found only in regions of geometrical irregularity causing flow separations and local vortex 
structures. 
Deviation of the mechanical environment of the cells from homeostatic levels stimulates vessel 
wall remodeling, increasing the production of structural proteins and degradative enzymes until a 
new homeostatic state is achieved.  The haemodynamic environment can give rise to deleterious 
remodeling.  For example, atherosclerotic lesions are found preferentially at bifurcations (4) and 
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the development of cerebral aneurysms is thought to be intimately linked to the WSS (5-8) 
although the exact mechanisms remain unknown. 
In this paper we focus on the interaction of WSS with the endothelium and discuss how ‘state of 
the art’ computer modeling techniques can provide valuable data to aid understanding.  Such 
data may be used to inform experiment and further, may help identify the key features of this 
complex system. 
The endothelium forms a permeability barrier between blood flow and the underlying tissues of 
the vessel wall and regulates aspects of circulatory function.  A “healthy” endothelium favours 
vasodilatation, provides an anticoagulant, profibrinolytic boundary, thus inhibiting leukocyte 
adhesion and platelet aggregation, and exhibits anti-inflammatory, anti-proliferative and anti-
oxidant characteristics conducive to the maintenance of a functional artery.  Given this strategic 
role, it is not surprising that a dysfunctional endothelium, characterised by a reduced 
bioavailability of vasodilators and heightened state of endothelial activation, functions as a key 
mediator in the pathogenesis of arterial disease (9,10). 
The physical properties, structural arrangement and morphology of endothelial cells (ECs) are 
influenced by local mechanical forces.  Shear stress increases the stiffness and alters the viscous 
properties of these cells (11).  In vitro, ECs elongate, changing from a polygonal ‘cobblestone’ 
morphology to flattened, elongated ovoids under the influence of flow (Figure 1b). The degree of 
elongation correlates with the magnitude of the shear stress (12-15).  The type of shear stress is 
also relevant as, under oscillatory shear, cultured cells retain a polygonal shape (13).  In vivo, 
cells have been shown to orientate with the predominant local flow direction (16) and 
perpendicular to the direction of cyclic stretch (17) but the relative importance of the two different 
mechanical stimuli for the normal in vivo state is not clear (18).  Furthermore, local topography 
may itself influence local shear stress; alignment of ECs with the direction of flow reduces the 
maximum shear stress by 50% (12) demonstrating the intimate coupling between shear stress 
and endothelial organisation and morphology. 
In normal arteries, the magnitude of WSS typically ranges between 10 and 70 dynes/cm2 (1-7 
Pa).  A mean positive steady shear stress is thought to be the optimal situation and is 
characterised by low proliferation and increased cell survival times.  A number of beneficial 
effects are reported; cells align with the flow; integrin distribution is reorganized improving 
endothelial cell adhesion and anti-thrombic and vasoactive agents, namely nitric oxide, 
endothelium-derived hyperpolarizing factor, prostacyclin and endothelin are produced (19,20).  
These act on the adjacent vascular smooth muscle cells which regulate the diameter of the 
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vessel and thus control the local blood flow rate (21).  Locally-mediated regulation of vessel 
diameter helps to maintain WSS within the normal range. 
As discussed above, higher and lower values of WSS and of OSI are found at specific sites in the 
circulation in association with changes in geometry (a curvature, bifurcation, anastomosis or 
stenosis, for example) with the lowest values being found where the flow becomes unstable with  
associated flow separation, recirculation zones or stagnant regions.  Specific levels of shear 
stress are believed to result in increased levels of biomarkers associated with inflammatory 
pathways and ultimately predispose to atherosclerosis.  Historically, high WSS is considered 
atheroprotective (22), whereas low WSS is associated with atherogenesis (10).  A number or 
studies suggest that oscillatory shear is also detrimental; for example, Ku et al (23), report a 
correlation between atherosclerotic plaque location and areas of low and oscillating WSS in the 
human carotid bifurcation. An additional level of complexity is demonstrated by the results of in 
vitro studies indicating that ECs can sense temporal and spatial gradients of WSS (24-26). 
A membrane-bound macromolecular coating on the luminal surface of the endothelial cell, the 
glycocalyx, provides the interface between the endothelium cell and the blood.  Comprising 
sulphated proteoglycans, hyaluronan and glycoproteins, the glycocalyx has a net negative charge 
and is enhanced by the binding of blood-born molecules such as plasma proteins, enzymes 
cytokines, water and other molecules with cationic sites forming a layer ~500nm thick (27). As 
well as having a key function with respect to permeability and leukocyte interactions, it is believed 
to act as the primary mechano-transducer of fluid shear stress to the cytoskeleton (28). 
Mechano-transduction plays a key role in both the regulation of blood pressure and vessel 
response to shear stress.  Shear stress is transduced into chemical signals which activate 
signalling pathways controlling cell functionality, i.e. gene and protein expression (17).  
Mechanical stimuli are also converted into intracellular signals that affect the proliferation, 
apoptosis, migration and permeability of the ECs and remodelling of the arterial wall (24,29). 
Whilst there is a substantial literature describing the influence of shear stress on ECs, most data 
has been obtained from in vitro experiment using rigid flow chambers and well-characterised 
flows. In this situation, WSS can be calculated with a reasonable level of confidence. In vivo, the 
situation is more complex and WSS is estimated from the mean volumetric flow and velocity of 
blood recorded in the vessel, vessel diameter and blood viscosity.  The values obtained represent 
the average value of WSS over a considerable area of the vessel wall and encompass 
populations of ECs rather than being descriptive of the level of exposure of the individual cell.  It 
can be argued that this is a reasonable approximation as there is evidence to suggest that there 
is significant interaction and intercellular signaling between ECs (30).  However it is not clear over 
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what length-scale this effect operates and the shear force experienced by an individual cell or 
small populations of cells of may be important. 
As will be seen, computational models of varying complexity can be used to give insight into 
some of these issues. 
Application of Computational Fluid Dynamics to Blood Flow 
Parallel with the introduction of computers since the Second World War has been the 
development of numerical methods, which enabled the governing partial differential equations to 
be modelled by equivalent equations which could be solved computationally (for example, finite 
difference equations).  These started to be of engineering significance in the 1960’s for solid 
stress analysis, where the fundamental science was applied to discrete small areas, termed finite 
element analysis. 
For fluids, the real breakthrough came at the end of the 1980’s when the first commercial 
Computational Fluid Dynamics (CFD) codes were introduced.  These enabled real problems to be 
addressed.  The codes were rapidly developed to be able to investigate three-dimensional (even 
time-dependent) irregular geometries.  Using the first release of the CFD code FLOW3D one of 
us (MWC) initiated research into the haemodynamics of arterial bifurcations.  A review by Xu and 
Collins (31) showed that, in order to be meaningful clinically, a model should have the potential to 
address: a] the time-dependent pulsatility of blood flow, b] the non-Newtonian character of blood 
(ie the non-linear relationship between viscosity and shear stress), c] the 3D geometry of the 
arterial system, and d] its time-dependence due to the distensibility of the arterial wall.   
A number of data sources are essential to the development of a computational model.  For 
cardiovascular models these include; a description of the boundary conditions (the set of 
conditions specified for the behaviour at the boundary of the domain), a 3D description of the 
geometry, a description of the material behaviour (eg. blood viscosity and arterial stiffness) and 
the availability of an appropriate set of validation data against which some basic feature of the 
output of the model can be tested.  Boundary conditions are important in determining the 
mathematical solutions to many physical problems and compensate for the fact that it is not 
feasible to model a system in its entirety.  In the context of a cardiovascular model they include 
physical properties such as pressure or flow at the inlet and outlet of the domain.  An in vitro set 
of experiments by carried out by Moravec and Liepsch (32) involved these four aspects, and was 
used as a test for the model (33), as were subsequent in vivo canine bifurcation data (34). The 
model was then extended to be able to use clinical Magnetic Resonance (MR) data for input 
boundary conditions for the CFD code; this also involved image processing studies (35). Finally, 
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the addressing of wall distensibility (a fluid-structure interaction-FSI-problem) proved a 
challenging task. Because of the complexity and non-linearity of the Navier-Stokes equations, 
only a few analytical solutions exist, and it is noteworthy that one of these 'classic' fluid dynamic 
cases, that of Womersley (36), related to pulsatile blood flow and arterial wall movement. A 
number of alternative FSI models were successfully tested by the group in question, all using 
Womersley’s data for code validation (37).  
CFD codes have now been combined with solid mechanics FEA codes to give immediate FSI 
capability.  One barrier to using this approach for cardiovascular vessels is the lack of information 
on the constraints applied to vessel wall motion in vivo.  An alternative solution is to use time 
series image data to prescribe wall motion.  The Sheffield group recently used this method in a 
study characterising the haemodynamics of the human superior mesenteric artery (SMA).  This 
work was motivated by the observation that, in comparison to many other arteries, the SMA is 
largely spared from primary atherosclerotic disease (38).  The parent vessel, the abdominal aorta, 
has been shown to be a principal site for the development of atherosclerotic lesions (39) as are 
the immediate proximal (coeliac) and distal (renal) branches.  A fully transient, CFD model was 
constructed of a segment of the abdominal aorta and SMA.  The geometry was based on 
dynamic MR imaging data and boundary conditions (flow), were determined from phase contrast 
MR velocity measurements (40). 
Figure 3 
The resulting OSI map for the model is shown in Figure 4a.  OSI is, in general, lower in the SMA 
than in the aorta.  The only area of high OSI in the SMA is at the root of the vessel as it leaves 
the aorta. This and correlates with clinical observations for atheroma.  Figure 4b illustrates the 
time varying WSS for two areas of the vessel wall exposed to a high or low level of OSI. 
The sequence described above exemplifies how basic science expressed in novel technology 
can be incorporated into clinical research and early demonstrators of the integration of a 
simulation chain into a clinical workflow are taking place in the AneurIST project 
(www.aneurIST.org). 
Introducing an additional level of complexity, some of the concepts discussed previously 
(computational assessment of haemodynamic loads, tissue remodelling, endothelium signaling 
etc.) can be incorporated in coupled computational simulation frameworks that enable us to 
examine the interaction of the various physiological processes and evaluate the relative 
importance of mechanisms that are explicitly incorporated into such models.  The models have 
practical applications, in particular, for disease evolution prediction for patient-specific cases. 
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Moreover, they are proving invaluable in the challenging task of hypothesis evaluation; they are 
highly effective tools to test and evaluate competing theories, since they allow the interrogation of 
disease progress scenarios. 
Simulation of the evolution (inception, growth and rupture) of cerebral aneurysms by the group at 
the University of Oxford provides an illustrative example of this type.  Aneurysm risk evaluation 
involves a variety of factors including; genetics, geometry of the vasculature, mechanical 
properties of the tissue and blood flow details and is therefore a particularly sensitive and 
biologically-dependent process. 
The first stage is to estimate the haemodynamic loads (pressure and WSS) that act on the 
aneurysm (and parent artery) using a finite volume technique.  The distribution of WSS on the 
inner surface of the aneurysm is computed and used to model the hypothetical response of the 
endothelium, which subsequently signals the smooth muscle cells and fibroblasts and leads to a 
remodeling and growth/atrophy of the elastin and collagen in the arterial wall.  This results in 
changes in the mechanical properties of the aneurysm and the geometry adapts to maintain 
mechanical equilibrium; a finite element method is used to solve the updated deformation field.  
The new geometry will result in a change in the haemodynamics and thus the WSS distribution.  
The updated flow field is solved and the computational cycle is repeated until the aneurysm 
stabilises in size or until the loads imposed exceed the load-bearing capacity of the wall leading 
to rupture. 
Figure 4 
Such integrative models can be used to evaluate whether hypothesised growth mechanisms yield 
predictions consistent with in vivo and in vitro observations, eg. relating the growth and 
remodeling of the arterial wall to the haemodynamic stimuli that act on the ECs.  For instance, the 
magnitude of the spatial WSS gradient (WSSG) has been proposed as one possible 
haemodynamic parameter which is correlated with regions of pathological remodelling (7,41).  As 
an aneurysm adapts the WSSG spatial distribution (see Figure 4) acting on the endothelium will 
change substantially and thus an understanding of how this affects the subsequent remodeling of 
the tissue is of critical importance.  Current research focuses on investigating hypotheses 
coupling the remodeling to such haemodynamic influences. 
Requirement for Analyses on Micro and Mesoscales. 
Now that macro-scale modelling is relatively commonplace, current focuses include the necessity 
to investigate very fine scales together with their impact on behaviour at conventional scales and 
at the levels of the organ and organism.  Work in progress at the University of Brunel 
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investigating the interaction of intravascular devices with the arterial wall, specifically; the Intra 
Aortic Balloon Pump (IABP) and vascular stent demonstrates a need to address smaller scales in 
general and the endothelium (and possibly the glycocalyx) in particular. 
The Intra Aortic Balloon Pump (IABP) is a widely-used cardiac assist device.  The balloon, usually 
inserted in the abdominal aorta via the iliac artery, is inflated and deflated every-, every other- or 
every second cardiac cycle. Inflation takes place during diastole and deflation during systole with 
the aim of increasing coronary flow and reducing left ventricular after-load.  Inevitably, the balloon 
contacts the inner wall of the aorta with every inflation/deflation cycle.  This repeated event (and 
possible contact with atherosclerotic plaque) has been reported to be responsible for balloon 
rupture.  However, no systematic study has been performed to investigate the mechanical effects 
of balloon/wall interaction.  Furthermore, as the balloon approaches the endothelium, a volume of 
blood is displaced proximally and distally.  This squeezing process generates shear stresses 
which, as yet, remain to be quantified.  Similarly, when the balloon moves away from the 
endothelium during deflation, it will generate micro pressure differences that may impose 
stretching (pulling) stresses on the ECs.  A very high spatial resolution is required in order to 
understand this process fully and to interpret the effects at the cellular level. 
As this issue has not been investigated, manufacturers have made no attempt to increase the 
diameter of the balloon, despite their conviction that a larger diameter would yield a better clinical 
outcome.  Improved understanding of the balloon/wall interaction may allow the balloon diameter 
to be increased whilst reducing the risk of adverse events. If the balloon is inflated and deflated 
once every cardiac beat, for an average patient using the IABP for 3 days, there will be 
approximately 250,000 incidents of frictional contact between balloon and aortic wall.  Data is 
available on the effect of imposing stresses on the endothelium layer for a few hours (42) but the 
influence of cyclical effects for longer periods is unknown.  The answer to this question may offer 
clinicians a maximum safe period for using the IABP before the endothelium begins to be 
damaged. 
Information on micro-scales is also important when evaluating the performance of vascular 
stents.  Stenting has two primary clinical objectives: to mechanically dilate a stenosed artery and 
to have minimal detrimental impact upon local blood flow characteristics.  Stents are clearly 
effective in opening up diseased arteries and restoring flow.  However, at the near-wall micro-
scale, the situation is less satisfactory. The thin (~100μm) stent struts apply stresses to the 
endothelium and glycocalyx and the local flow is disturbed causing further interaction with 
endothelial topography.  Macroscopic models, such as those described by Raedelli et al capture 
important details of the flow but are not resolved to cellular and sub-cellular length-scales (43) 
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Recent numerical modelling studies investigated the effect of endothelial topography on the 
calculation of WSS (44),(45).  The influence of pulsatile flow on WSS is also of interest in terms of 
the temporal values that exceed certain high or low values, often associated with recirculation 
near the stent wires especially on the leeward side(46).  In describing performance, a key 
challenge is how to summarise the spatial and temporal WSS values, without loss of important 
information. 
Considerable computing resource is required to model a stented artery in its entirety with 
resolution of the fine detail of the stent struts and local blood flow.  So much so, that often studies 
are confined to a ‘representative’ portion of the stented artery.  This assumes symmetry, which is 
frequently not the case, and means that understanding the role of the stent as a whole is 
obscured.  Add to this an interest in the interaction of the stent with blood cells, ECs and/or the 
glycocalyx and the model resolution required becomes too demanding for resolution with 
sufficient detail with conventional CFD.  As will be discussed below, one way of a addressing this 
is to use a multi-scale approach. 
Multi-scale and multi-physics modelling techniques.  
There is ever-increasing accessibility of relatively inexpensive computing power but the tendency 
is to create models of increasing complexity thus challenging whatever computational resource 
might be available.  The optimal strategy is to use models of no greater detail than the processes 
for the particular scale demand.  Multi-scale modeling embodies the efficient combination of such 
scale-related models and it is increasingly used in science and engineering as a powerful tool for 
making simulation of complex biological systems computationally tractable.  This approach has 
been adopted in the successful UPS Physiome Project (47). 
Human physiology systems are multi-scale, multi-science systems, encompassing a range of 
phenomena including molecular and cellular biology, physics, medicine, and engineering and 
crossing many orders of magnitude in terms of temporal and spatial scales.  The challenge is how 
best to integrate these different aspects into the model.  An approach is needed to break the 
system down into a number of single-scale models which can then be coupled and interact 
across the scales. 
A Scale Separation Map (SSM) on which each single-scale system is represented as an area 
according to its spatial and temporal scales helps in the identification of key processes having 
well-separated scales as the components of the multi-scale model.  The EU-funded COAST 
[Complex Automata Simulation Technique] project (www.complex-automata.org)(48) is 
developing this concept and employing  it to model the complex process of coronary artery in 
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stent restenosis.  Details can be found in Evans et al (49).  To illustrate the principles of this 
modeling paradigm a SSM has been developed demonstrating how the interaction of blood flow 
and the vessel wall can be represented in this way. 
Figure 5 here. 
It must be emphasised that the SSM is not a definitive representation of a system.  The 
placement and degree of resolution of sub-systems reflects the extent of the domain which is to 
be modelled and the availability of quantitative data to support the models.  The map aims only to 
provide information about how any two processes are separated and must subsequently be 
coupled.  An interesting observation is that the biologists, clinicians, physicists and engineers 
working on the development of the SSM found it to be a very useful conceptual tool for arranging, 
cataloguing and formalising existing knowledge, and for identifying gaps in the current knowledge 
base and thus informing future experiments. 
Within the COAST project agent-based models are used to represent the ECs and smooth 
muscle cells.  The software agent is an intuitively natural computational representation of a real 
world entity.  It is applicable to any system where emergent behaviour arises as a result of the 
complex interactions between many individuals, and is particularly appropriate in the case of 
modeling biological tissues where tissue behaviour is an emergent property of the responses and 
interactions of individual cells.  At the simplest level, the observed behaviour of the real-world 
cells are represented by simple logical rule sets that determine the responses of individual 
software agents to various stimuli  (eg rules can represent apoptosis, change in morphology or 
progression through the cell cycle in response to a sensed diffusive signal or a shear stress).  
This paradigm has previously been used to model the behaviour of growing epithelial cell 
populations, and the response of confluent monolayers to scratch wounding (50,51).  The 
application of agent modeling of endothelial tissue allows the potential heterogeneity of individual 
ECs to be explicitly represented, with each cell permitted to react differently depending on its 
gene/protein expression and differences in the local modeled flow field. Sub-models of signaling 
processes could also be incorporated as an extension to the logical rule sets, thus adding a 
further layer of complexity to the model. 
Another  possibility is to explicitly include the blood cells in the flow model.  The CFD analyses 
described previously treat blood as a continuous fluid flow and represent the vascular 
endothelium as a constant, locally smooth velocity (Dirichlet) boundary condition. In reality, the 
vessel walls encounter Newtonian plasma, which advects discrete, embedded cells. These will 
encounter the vessel wall in different ways, according to local flow conditions, geometry and cell 
concentration. 
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Figure 6 
Figure 6, represents a simplified, two-dimensional calculation of flow in the region of an explicitly 
modelled single detaching leukocyte, traditionally represented as a wetting drop of immiscible 
fluid. These results, obtained using multi-component lattice Boltzmann (LB) simulation, illustrate 
the complexity of flow in the region of a single cell contact with an idealised boundary. Plainly 
there is no such thing as a microscopically steady WSS - even in steady macroscopic vessel flow. 
Little imagination is necessary to see that, at normal haematocrit concentrations of advected 
erythrocytes, near-wall flow (and hence WSS distribution) becomes exceedingly complex. 
Retaining such short length and time scale physics is central to understanding the response of 
ECs.  To do so requires novel flow computation methods which are “two-way coupled” to the 
agent models (as outlined above) and which can also address other issues discussed briefly 
below. Capture of complex interactions between a representative number of explicitly modelled 
erythrocytes is necessary and the need to model ingress of atherosclerotic agents at exposed 
endothelial cell boundaries (to inform coupled agent models) requires coupled plasma species 
diffusion-advection. Therefore, a multi-physics flow technique, able efficiently to handle many 
erythrocytes, is required. Incorporation of the cellular WSS morphological response (mediated by 
agent models) as explicitly resolved, geometrically complex Dirichlet boundary conditions 
requires a suitably adaptable flow technique. Finally, the overall computational demands point to 
a parallelizable algorithm. The multi-component LB Equation simulation method has all these 
attributes (52). The application of this particular variant of LB used to obtain the data shown in 
figure 6 (53) to the problem of wetting is described in detail in Hollis et al (54). 
CONCLUSIONS 
The use of computational methods for medical applications is now commonplace in the research 
community but not, as yet, in routine clinical practice.  Complex simulation chains which facilitate 
CFD analyses of models developed from patient-specific geometries are capable of providing 
information which, because of limitations of current investigative techniques (in terms of 
resolution or the need for direct visualisation by microscopic imaging of fluorescent particles for 
example), is not available from clinical studies or experiment (Reneman et al 2006). 
The ultimate aim is to produce systems which couple haemodynamics with models of biological 
phenomena to test hypotheses or predict the likely outcome of a disease or an intervention; the 
potential power of such models is beginning to be recognised and new technologies are being 
developed in order to cope with the challenges presented by such complex systems.  This 
includes methodology to enable the integration of models of different type, levels of complexity 
and scales.  However, the greatest challenge, and the ultimate goal, is the translation of this 
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technology to the clinical arena.  Data reduction is a key element; models can produce complex 
and detailed outputs which must be summarised to give clinical meaningful indices. It must also 
be borne in mind that the engineering procedures of code validation/verification need to be 
carefully followed. Access to validation data is of paramount importance and it is essential 
clinicians and biologists are engaged fully at an early stage.  The final tools must also be tested 
and validated by the clinical end users.  
A number of exciting initiatives are poised to accelerate progress and uptake in this area.  In 
recognising the potential of ICT-based tools for modeling and simulation of human physiology and 
disease-related processes, the EU is funding a number of collaborative projects directed towards 
the development of patient-specific computer models for personalised and predictive healthcare 
under the banner of the Virtual Physiological Human(55) (56). A networking action (the VPH 
Network of Excellence) within the recent funding call will support the research community, and lay 
foundations for methodological, technical and training frameworks to support such research.  
The authors wish to acknowledge the support of the EU Sixth Framework programme (AneurIST, 
COAST) and BRET (The Bardhan Research and Education Trust) for aspects of this work. 
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Figure Legends 
Figure 1  Schematic model of the major components of a healthy elastic artery showing the three 
layers of the wall: the intima,  media and adventitia and the distribution of endothelial and smooth 
muscle cells. 
Figure 2  a The mechanical environment of the artery showing the distribution of stresses in the 
wall. b. The influence of shear stress on endothelial cell morphology. 
Figure 3 Subject-specific CFD model of the abdominal aorta and a major branch, the superior 
mesenteric artery.  Figure 3a shows distribution of OSI.  The region of high OSI (arrowed) the 
proximal lip of the outlet of the origin of the SMA from the aorta corresponds with the normal 
distribution of atheroma reported for this artery.  Figure 3b shows plots of different time varying 
WSS at two locations on the vessel wall.  One corresponds to an area of high OSI (top) and the 
second to an area of low OSI (bottom). 
Figure 4  Evolution of the wall shear stress spatial gradient [Pa/m] for an idealised aneurysm with 
a localized daughter bleb developing on the dome. Development of the aneurysm is accompanied 
by an increase in the WSSG around it's base: this may have significant implications for the 
degenerative remodelling of the tissue in this region and thus future growth of the aneurysm.  At 
/t/=10, a daughter bleb begins to develop on the aneurysm dome. It can be seen that an annulus 
of high WSSG forms around the daughter bleb (/t/=12). This may result in further degeneration of 
the tissue in this region thus promoting the growth and enlargement (and possibly rupture) of the 
secondary bleb. 
Figure 5  Scale Separation Map (SSM)  The SSM is  defined as a two dimensional map with the 
horizontal axis coding for temporal scales and the vertical axis for spatial scales. Each subsystem 
occupies a certain area on this map. Arrows indicate coupling between the single scale sub-
systems. 
Figure 6  A time sequence figure produced with a lattice Boltzmann simulation. It shows a 2D 
drop initially attached to a flat boundary, subject, at time t=0, to a shear. The dark / light 
background shading identifies immiscible fluid components, the overlying contours a rectangular 
stream function calculated in the rest frame of the fluid.   
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